Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?

To: Jerry A. Balcolm who wrote (2711)	9/27/1999 11:20:00 PM
From: LT	Respond to of 2836

I think the key here for all of us is a means of generating financing for the company, prior to the marketing of any product, with no further dilution to current shareholders. Your 100% correct here, the company needs to generate financing to make marketing work. The thing here is that it is clear we have a product that someone has faith in, this is simply placing the needed machinery in motion to market a saleable product. It appears they will have a salable product or they think they will. How they choose to accomplish financing the marketing effort, is up to the company, they are in the better position to determine that, then us share holders are. I am looking for interest from a larger drug company and all that might bring. Time will tell. Regards LT